Properties of benzodiazepine receptors in rat retina.
D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D002531:Cerebellum / Q000032:analysis; D004974:Etazolate / Q000494:pharmacology; D005445:Flunitrazepam / Q000378:metabolism; D006624:Hippocampus / Q000032:analysis; D007559:Ivermectin / Q000031:analogs & derivatives*; D007783:Lactones / Q000494:pharmacology; D008970:Molecular Weight; D011724:Pyridazines / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000378:metabolism*; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter / Q000378:metabolism; D012160:Retina / Q000187:drug effects / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D000871:Anthelmintics; D014151:Anti-Anxiety Agents; D007783:Lactones; D011724:Pyridazines; D011955:Receptors, Drug; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter; D005680:gamma-Aminobutyric Acid; D005445:Flunitrazepam; C022120:avermectin B(1)a; C021604:CL 218872; D007559:Ivermectin; D004974:Etazolate